Kidney stone risk following modern bariatric surgery

Current Urology Reports

Volumn 15, Issue 5, 2014, Pages

  Gonzalez, Ricardo D ^a   Canales, Benjamin K ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Department of Urology ^*  (United States)

Author keywords

Bariatric surgery; Calcium oxalate stones; Gastric bypass surgery; Hyperoxaluria; Hypocitraturia; Morbid obesity; Nephrolithiasis

Indexed keywords

BARIATRIC SURGERY; CALCIUM OXALATE STONE; DISEASE ASSOCIATION; DISEASE MODEL; EXPERIMENTAL MODEL; HUMAN; HYPEROXALURIA; HYPOCITRATURIA; INCIDENCE; MALABSORPTION; NEPHROLITHIASIS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; RISK REDUCTION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; URINALYSIS; URINE VOLUME; ADVERSE EFFECTS; COMPLICATION; HEALTH; KIDNEY CALCULI; OBESITY, MORBID; RISK FACTOR;

BARIATRIC SURGERY; GLOBAL HEALTH; HUMANS; HYPEROXALURIA; INCIDENCE; KIDNEY CALCULI; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84896421654     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-014-0401-x     Document Type: Review

References (37)

1. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-55.
2. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519-22. (Pubitemid 29504044)
3. Demaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol Clin N. 2005;34:127-42.
4. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52. (Pubitemid 47295641)
5. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132:2253-71. (Pubitemid 46693754)
6. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1:481-5.
7. Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology. 2009;74:746-9.
8. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-17. (Pubitemid 41464692)
9. Park AM, Storm DW, Fulmer BR, et al. A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery. J Urol. 2009;182:2334-9.
10. Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010;211:8-15
11. •• Wu JN, Craig J, Chamie K, et al. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery. Surg Obes Relat Dis. 2013;9:83 -7. Recent prospective series showing increased urinary oxalate excretion after RYGB compared to preoperative samples.
12. Pang R, Linnes MP, O'Connor HM, et al. Controlled metabolic diet reduces calcium oxalate supersaturation but not oxalate excretion after bariatric surgery. Urology. 2012;80:250-4.
13. Froeder L, Arasaki CH, Malheiros CA, et al. Response to dietary oxalate after bariatric surgery. Clin J Am Soc Nephrol. 2012;7:2033-40.
14. Sakhaee K, Griffith C, Pak CY. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis. 2012;8:67-72.
15. Durrani O, Morrisroe S, Jackman S, Averch T. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol. 2006;20:749-52. (Pubitemid 44736251)
16. •• Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol. 2009;181:2573-7. Claims data from bariatric surgery and obese controls patients (n=4,639 respectively) showing near doubling of stone incidence post-RYGB.
17. Shimizu H, Ichikawa D, Tamagaki K, et al. Evaluation of postoperative nephrolithiasis and renal dysfunction in gastric cancer patients. Gastric Cancer. 2013;16:338-44.
18. • Chen T, Godebu E, Horgan S, et al. The effect of restrictive bariatric surgery on urolithiasis. J Endourol. 2013;27:242-4. Retrospective series highlighting low incidence (1%) of stone disease after restrictive bariatric surgery.
19. Hofmann AF, Laker MF, Dharmsathaphorn K, et al. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate. Gastroenterology. 1983;84:293-300. (Pubitemid 13224269)
20. Andersson H, Jagenburg R. Fat-reduced diet in the treatment of hyperoxaluria in patients with ileopathy. Gut. 1974;15:360-6.
21. •• Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654-61. One-year clinical and experimental investigation of plasma and urinary oxalate levels in 9 patients following RYGB, including evaluation of oxalate loading and fecal fat testing.
22. Dobbins JW, Binder HJ. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology. 1976;70:1096-100.
23. Siener R, Petzold J, Bitterlich N, et al. Determinants of urolithiasis in patients with intestinal fat malabsorption. Urology. 2013;81:17-24.
24. Freel RW, Hatch M, Earnest DL, Goldner AM. Oxalate transport across the isolated rat colon. A re-examination. Biochim Biophys Acta. 1980;600:838-43. (Pubitemid 10015644)
25. Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704-13.
26. • Canales BK, Ellen J, Khan SR, Hatch M. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate. J Urol. 2013;190:1102-9. New description of hyperoxaluria and fecal fat malabsorption in an RYGB model that holds promise for future investigations and therapies.
27. Allison MJ, Dawson KA, Mayberry WR, Foss JG. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol. 1985;141:1-7. (Pubitemid 15139551)
28. Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005;68:1244-9. (Pubitemid 43246443)
29. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007;177:565-9. (Pubitemid 46054037)
30. Patel BN, Passman CM, Fernandez A, et al. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009;181:161-6.
31. Maalouf NM, Tondapu P, Guth ES, et al. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol. 2010;183:1026-30.
32. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72:100-7. (Pubitemid 47014438)
33. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19:1605-11.
34. Penniston KL, Kaplon DM, Gould JC, Nakada SY. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol. 2009;182:2340-6.
35. Semins MJ, Asplin JR, Steele K, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010;76:826-9.
36. Costa-Matos A, Guidoni LR, Carvalho KA, et al. Is there an association between urolithiasis and Roux-en-y gastric bypass surgery? Int Braz J Urol. 2009;35:432-5.
37. Marceau P, Marceau S, Biron S, et al. Long-term experience with duodenal switch in adolescents. Obes Surg. 2010;20:1609-16.